Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Movement disorders
How do you decide between Vyalev and Onapgo for patients who would benefit from continuous dopaminergic stimulation?
Related previous discussion on
theMednet on Vyalev
.
Answer from: at Community Practice
Either is fine.
Sign In
or
Register
to read more
30087
Related Questions
What do you do for a patient with Parkinson's Disease and orthostatic hypotension who has failed midodrine, fludrocortisone, droxidopa, pyridostigmine, and atomoxetine?
How do you convert between tetrabenazine, deutetrabenazine, or valbenazine for management of tardive dyskinesia?
How do you decide between the different oral longer acting levodopa medications?
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
Do you consider DBS for Essential Tremor in patients who already underwent Focused Ultrasound Thalamotomy?
When should you suspect that palatal tremor could be a functional neurologic disorder?
Do you ever delay starting levodopa in patients with Parkinson's disease?
How do you manage levodopa in a patient with Parkinson's and RLS with augmentation?
How do you counsel patients on the cognitive effects of DBS for Parkinson's disease?
What considerations should you discuss with patients prior to genetic testing for suspected Huntington disease?